Skip to main content
Equibles
DOGP logo

DOGP · Dogecoin Cash, Inc. · Metrics

Track DOGP — free

Use DOGP with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DOGP.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.01 +0.00 (+3.13%) At close · Oct 20
Rebalance outlook locked
Going-concern doubt — flagged Aug 19, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The Company has an accumulated deficit of $84,714,880 at June 30, 2026, which, among other factors, raises substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 19, 2026
Market Cap
$1.04M
Shares
162.61M
Volume · Oct 20 154.44K Avg daily vol (3M) 370.61K

DOGP metrics

69 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.01
Market cap
$1.04M

Price action

20 metrics
Price change (1W)
+13.8%
Price change (30D)
-18.5%
Price change (3M)
-19.5%
Price change (6M)
-53.5%
Price change (YTD)
-61.4%
Price change (1Y)
-77.9%
Trailing year
Price change (5Y)
-98.0%
52-week high
$0.03
52-week low
$0.01
Change from 52-week high
-77.9%
Change from 52-week low
+13.8%
Annualized volatility
106.6%
Annualized volatility (3M)
132.0%
Beta
-0.4
RSI (14D)
42.9
Price vs SMA 50
-16.0%
Price vs SMA 200
-46.5%
Avg volume (3M)
372,838
Relative volume
0.3
Average dollar volume
$3,108

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
162.61M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.4×
reciprocal yield 70.4%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-290.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
64.5%
Operating margin
-73.7%
Trailing 12 months
Net margin
-413.0%
Gross profit (TTM)
$465,499
Operating profit (TTM)
−$531,830
Net income (TTM)
−$2.98M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.06
Gross profit per diluted share (TTM)
$0.04
Operating profit per diluted share (TTM)
$-0.06
EBITDA per diluted share (TTM)
$-0.06
Net income per diluted share (TTM)
$-0.09
Operating cash flow per diluted share (TTM)
$-0.03
Free cash flow per diluted share (TTM)
$-0.01
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.01

Growth

11 metrics
Revenue growth YoY
-13.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$721,379
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+16.6%
Year over year · more shares
Revenue CAGR (3Y)
-22.0%
Revenue CAGR (5Y)
-17.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-137.4%
Debt / equity
—
Current ratio
1.0
EBITDA (TTM)
−$530,671
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
-5.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$10,971
Latest balance sheet
Cash & equivalents
$10,971
Total assets
$2.17M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$66,923
Capital expenditures (TTM)
$46,677
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
1
13F filer change QoQ
0
Institutional ownership
0.0%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
0.0%
Active holders' share change QoQ
+0.0%
Holder tenure
26.0
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
27 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$18,505
Insider-sentiment score
39 / 100

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1360442 CUSIP 13764T105 Visit website Investor relations